sorafenib 失效, 肺转伴有症状,精神不佳. 目前还能travel, 寻求更新疗法, 包阔药试 - HK, 台湾, US. 谢谢关爱.
详情
Pathology report (by pathologist from Fudan University affiliated Sun Yat-sen Hospital) 复旦大学附属中山医院病理报告
female, primary HCC diagnosed Nov 2011
女, 65 岁, 55 KG (58 KG presurgery). 原发性肝细胞肝癌
1) greyish white liver mass, 7.5x6 cm, adjacent to capsular, with 10+ satelite lesions, ranging 0.2 - 0.8 cm in diameter.
肝肿块 7.5x6 cm, 紧贴肝被膜,子灶10余个,大小不等, 周围肝土黄色, 细腻
2) also seen greyish white mass 5x5x4 cm with membrane, section face grey to brown in color, partially hemorragic. Alongside gastric tissue measuring 4x2x1 cm
另见灰白带包膜肿物一个, 5x5x4 cm, 切面灰褐, 部分出血, 旁附少许胃组织, 大小 4x2x1 cm
Diagnosis: right-side hepatocellular carcinoma, grade II - III with 2ndary lesions, sorrounding hepatic tissue G1S0; spleen and stomach interstitial stromal tumor,
诊断: 右边原发性肝细胞肝癌 II 到 III 级, 伴子灶, 周围肝G1S0; 胃/脾间质瘤, 细胞丰富, 轻度异型, 核分裂相难见.
Treatment history
治疗史
Nov 18, 2011 - surgery. Section VI, VII, VIII and partial diaphram resected, stomach partly removed due to GIST 肝六,七,八区切除,部分纵隔,部分胃切除
Nov 18, 2011 - TACE: EADM (表阿霉素) and Lipiodol (碘油)
Feb 7, 2012 - TACE. Mets to both lungs 双肺多点转移. Starting sorafenib, 800mg + 800mg per day
Jun 15, 2012 - TACE. Stopped sorafenib
Aur 9, 2012 - TACE + BAI
Aug 16, 2012 - resuming sorafenib 800 mg + 400 mg per day
Laboratory
AFP 60500
CEA 2.17
CA19-9 9.4
AST 66
AP 84
GGT 174
Bile acid 52.0
bilirubin - slightly elevated, 22.4 total/ 7.4 conjugated
kidney function - normal, creatinine 45, urea 1.6 (low), uric acid 159, eGFR 121
